Mr Kho is the Non-Executive Chairman and an Independent Director of the Company. He was appointed to the Board as an Independent Director on 15 May 2025 and was subsequently appointed as Chairman of the Board on 26 November 2025. He also serves as the Chairman of the Audit Committee and a member of the Nominating Committee and the Remuneration Committee.
Mr Kho holds a Bachelor of Business (Financial Analysis) with a minor in Applied Economics from Nanyang Technological University, Singapore and graduated with Second Upper Honours. He is also a Chartered Financial Analyst.
Mr Kho has more than 20 years of experience in investments, investment banking and regulatory affairs. He is currently the Chief Executive Officer of Willan Capital Pte. Ltd., an investment management firm he has led since 2013. Earlier in his career, he served in the Issuer Regulation Department of Singapore Exchange Securities Trading Limited, where he was involved in the review of listing applications and regulatory compliance of listed companies. He has also held independent directorships in several SGX-listed companies, bringing extensive experience in corporate governance, capital markets and board oversight.
Mr Kho is the Non-Executive Chairman and an Independent Director of the Company. He was appointed to the Board as an Independent Director on 15 May 2025 and was subsequently appointed as Chairman of the Board on 26 November 2025. He also serves as the Chairman of the Audit Committee and a member of the Nominating Committee and the Remuneration Committee.
Mr Kho holds a Bachelor of Business (Financial Analysis) with a minor in Applied Economics from Nanyang Technological University, Singapore and graduated with Second Upper Honours. He is also a Chartered Financial Analyst.
Mr Kho has more than 20 years of experience in investments, investment banking and regulatory affairs. He is currently the Chief Executive Officer of Willan Capital Pte. Ltd., an investment management firm he has led since 2013. Earlier in his career, he served in the Issuer Regulation Department of Singapore Exchange Securities Trading Limited, where he was involved in the review of listing applications and regulatory compliance of listed companies. He has also held independent directorships in several SGX-listed companies, bringing extensive experience in corporate governance, capital markets and board oversight.
Dr Liu is the Executive Director and Chief Technical Officer of the Company. He is responsible for leading the Company’s research and development, technical operations and product innovation efforts. He was appointed to the Board on 17 October 2025.
Dr Liu has more than 20 years of experience in applied chemistry, fine chemicals industry, spanning technical management, plant operations and senior executive leadership in the People’s Republic of China. Prior to joining the Company, he has held various senior roles including General Manager of Fuzhou Xingchen Pharmaceutical Co., Ltd. (2021–2022), General Manager of Hengshui Quark Biotechnology Co., Ltd. (2023–2024), Special Advisor to the General Manager of Hunan Ruiguan Biotechnology Co., Ltd. (2024–2025) and Deputy General Manager and Director of the Technical Center at Hunan Jingfeng Chemical Technology Co., Ltd. (2025). From 2014 to 2021, he served as Executive Manager of Amly Chemicals Co., Ltd., a former wholly-owned subsidiary of the Company, on secondment from Shanghai Matex Chemicals Co., Ltd. (a 60%-owned subsidiary of the Company), where he oversaw production, technical development and sales.
Earlier in his career from 2012 to 2014, Dr Liu was the General Affairs Manager of Shanghai Matex Chemicals Co., Ltd. where he supported administration, logistics, quality control and sales. He has since continued to deepen his expertise in dyestuff intermediates, specialty chemicals and related biotech applications, and plays a key role in driving the Group’s technology roadmap and application development.
Dr Liu holds a PhD in Applied Chemistry from Dalian University of Technology and a Master of Science degree in Applied Chemistry from Qiqihar University.
Dr Liu is the Executive Director and Chief Technical Officer of the Company. He is responsible for leading the Company’s research and development, technical operations and product innovation efforts. He was appointed to the Board on 17 October 2025.
Dr Liu has more than 20 years of experience in applied chemistry, fine chemicals industry, spanning technical management, plant operations and senior executive leadership in the People’s Republic of China. Prior to joining the Company, he has held various senior roles including General Manager of Fuzhou Xingchen Pharmaceutical Co., Ltd. (2021–2022), General Manager of Hengshui Quark Biotechnology Co., Ltd. (2023–2024), Special Advisor to the General Manager of Hunan Ruiguan Biotechnology Co., Ltd. (2024–2025) and Deputy General Manager and Director of the Technical Center at Hunan Jingfeng Chemical Technology Co., Ltd. (2025). From 2014 to 2021, he served as Executive Manager of Amly Chemicals Co., Ltd., a former wholly-owned subsidiary of the Company, on secondment from Shanghai Matex Chemicals Co., Ltd. (a 60%-owned subsidiary of the Company), where he oversaw production, technical development and sales.
Earlier in his career from 2012 to 2014, Dr Liu was the General Affairs Manager of Shanghai Matex Chemicals Co., Ltd. where he supported administration, logistics, quality control and sales. He has since continued to deepen his expertise in dyestuff intermediates, specialty chemicals and related biotech applications, and plays a key role in driving the Group’s technology roadmap and application development.
Dr Liu holds a PhD in Applied Chemistry from Dalian University of Technology and a Master of Science degree in Applied Chemistry from Qiqihar University.
Ms. Sim is an accomplished leader with over 28 years of experience spanning corporate governance, finance, strategy, and business operations. Up until June 2025, she was the Managing Director of Advancer Global Limited’s subsidiary, Newman & Goh Property Consultants Pte. Ltd. (currently Newman SRE Pte. Ltd.), where she managed full business operations, financial compliance, and corporate development. Since 2022, she has served on the Strata Titles Board, Singapore.
In her new appointments, Ms. Sim will chair the Nominating Committee and join the Audit and Remuneration Committees.
Ms. Sim is an accomplished leader with over 28 years of experience spanning corporate governance, finance, strategy, and business operations. Up until June 2025, she was the Managing Director of Advancer Global Limited’s subsidiary, Newman & Goh Property Consultants Pte. Ltd. (currently Newman SRE Pte. Ltd.), where she managed full business operations, financial compliance, and corporate development. Since 2022, she has served on the Strata Titles Board, Singapore.
In her new appointments, Ms. Sim will chair the Nominating Committee and join the Audit and Remuneration Committees.
Dr Fu is an Independent and Non-Executive Director of the Company. He was appointed to the Board on 5 February 2026. He also serves as the Chairman of the Remuneration Committee and a member of the Audit Committee and the Nominating Committee.
Dr Fu has deep academic and research experience in textile science and engineering, having held a series of senior positions at Jiangnan University in the People’s Republic of China. From January 2015 to December 2016, he was Vice Dean of the Institute of Science and Technology and Director of the Military Industry Office at Jiangnan University. From January 2017 to November 2025, he served as Dean of the College of Textile Science and Engineering at Jiangnan University, and since November 2025, he has been Director of the Department of Development Planning and Discipline Construction at Jiangnan University. His research work includes contributions in areas such as biobased flame-retardant materials and dye chemistry pedagogy, underscoring his technical expertise relevant to the Group’s specialty chemical and textile-related businesses.
Dr Fu holds a PhD in Textile Science and Engineering from Jiangnan University, as well as a Master’s degree in Materials Science and a Bachelor’s degree in Polymer Materials Science and Engineering, both from Qingdao University.
Dr Fu is an Independent and Non-Executive Director of the Company. He was appointed to the Board on 5 February 2026. He also serves as the Chairman of the Remuneration Committee and a member of the Audit Committee and the Nominating Committee.
Dr Fu has deep academic and research experience in textile science and engineering, having held a series of senior positions at Jiangnan University in the People’s Republic of China. From January 2015 to December 2016, he was Vice Dean of the Institute of Science and Technology and Director of the Military Industry Office at Jiangnan University. From January 2017 to November 2025, he served as Dean of the College of Textile Science and Engineering at Jiangnan University, and since November 2025, he has been Director of the Department of Development Planning and Discipline Construction at Jiangnan University. His research work includes contributions in areas such as biobased flame-retardant materials and dye chemistry pedagogy, underscoring his technical expertise relevant to the Group’s specialty chemical and textile-related businesses.
Dr Fu holds a PhD in Textile Science and Engineering from Jiangnan University, as well as a Master’s degree in Materials Science and a Bachelor’s degree in Polymer Materials Science and Engineering, both from Qingdao University.
